Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced anticancer activity.

seliciclib (CYC202) - Cyclacel, Cedars-Sinai

http://www.ncbi.nlm.nih.gov/pubmed/38696844

Ghada F Elmasry; Nehad Abou-Elmagd El-Sayed; Ola Alaa Hamed; Walaa R Mahmoud

May 2, 2024